MICALE, Vincenzo, Di Bartolomeo MARTINA, Di Martino SERENA, Tibor ŠTARK, Bernardo DELL'OSSO, Filippo DRAGO and Claudio ADDARIO. Are the epigenetic changes predictive of therapeutic efficacy for psychiatric disorders? A translational approach towards novel drug targets. PHARMACOLOGY & THERAPEUTICS. OXFORD: PERGAMON-ELSEVIER SCIENCE LTD, 2023, vol. 241, January 2023, p. 1-39. ISSN 0163-7258. Available from: https://dx.doi.org/10.1016/j.pharmthera.2022.108279.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Are the epigenetic changes predictive of therapeutic efficacy for psychiatric disorders? A translational approach towards novel drug targets
Authors MICALE, Vincenzo (guarantor), Di Bartolomeo MARTINA, Di Martino SERENA, Tibor ŠTARK (703 Slovakia, belonging to the institution), Bernardo DELL'OSSO, Filippo DRAGO and Claudio ADDARIO.
Edition PHARMACOLOGY & THERAPEUTICS, OXFORD, PERGAMON-ELSEVIER SCIENCE LTD, 2023, 0163-7258.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30104 Pharmacology and pharmacy
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 13.500 in 2022
RIV identification code RIV/00216224:14110/23:00130255
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1016/j.pharmthera.2022.108279
UT WoS 000906912700004
Keywords in English Schizophrenia; Bipolar disorder; Depression; DNA methylation; Epigenetics; Antidepressants; Antipsychotics
Tags 14110516, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 31/1/2023 10:39.
Abstract
The etiopathogenesis of mental disorders is not fully understood and accumulating evidence support that clinical symptomatology cannot be assigned to a single gene mutation, but it involves several genetic factors. More specifically, a tight association between genes and environmental risk factors, which could be mediated by epigenetic mechanisms, may play a role in the development of mental disorders. Several data suggest that epigenetic modifications such as DNA methylation, post-translational histone modification and interference of microRNA (miRNA) or long non-coding RNA (lncRNA) may modify the severity of the disease and the outcome of the therapy. Indeed, the study of these mechanisms may help to identify patients particularly vulnerable to mental disorders and may have potential utility as biomarkers to facilitate diagnosis and treatment of psychiatric disorders. This article summarizes the most relevant preclinical and human data showing how epigenetic modifications can be central to the therapeutic efficacy of antidepressant and/or antipsychotic agents, as possible predictor of drugs response.
PrintDisplayed: 21/6/2024 14:18